Rare diseases
Investigational molecules
Locations
Skaftahlid 24, 105 Reykjavik, Iceland
Landspitali supports clinical research in multiple myeloma and smoldering multiple myeloma, with attention to both intermediate-risk and high-risk disease. Its research activity includes evaluation of treatment strategies aimed at disease control and deeper response in patients with plasma cell malignancies.
These studies reflect a focus on blood cancer management within a hospital-based clinical research setting in Iceland.
Landspitali runs clinical trials in conditions such as Dyspepsia, Plasma cell myeloma, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
IcelandIcelandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
